FindTrial
Sign In

A study of clinical assessment and nutritional intervention in cognitively impaired patients with sarcopenia

A study of clinical assessment and nutritional intervention in cognitively impaired patients with sarcopenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087204
Enrollment
Unknown
Registered
2024-07-22
Start date
2024-04-20
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cognitive impairment

Interventions

intervention group:Nutritional food containing ginsenoside and CaHMB
control group:placebo

Sponsors

The Sixth Affiliated Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: According to the 2011 edition of the US NIA-AA and ASA/AHA standards, as well as the 2014 edition of the Vas Cog standards, patients diagnosed with cognitive impairment accompanied by sarcopenia.

Exclusion criteria

Exclusion criteria: Patients with other neurological, psychiatric, and cerebrovascular diseases, a history of taking antipsychotic drugs, a score greater than 4 on the Hachinski ischemic scale, and a history of obesity, alcoholism, and drug abuse.

Design outcomes

Primary

MeasureTime frame
Mini-Mental State Examination, MMSE;Montreal Cognitive Assessment(MoCA);appendicular skeletal muscle mass index;grip strength;—

Secondary

MeasureTime frame
urine AD7c-NTP;Routine clinical data;Pittsburgh Sleep Quality Index (PSQI);Hospital Anxiety and Depression Scale (HADS);—

Countries

Chian

Contacts

Public ContactLi Zhong

The Sixth Affiliated Hospital, Sun Yat-sen University

lzhong@mail.sysu.edu.cn+86 181 2232 9336

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026